Published in Transplantation on December 15, 2012
Analysis of adult 20-year survivors after liver transplantation. Hepatol Int (2014) 1.45
Portomesenteric shunt for liver transplantation and complete portal vein thrombosis. Transplantation (2013) 1.07
Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol (2015) 0.94
Portal vein thrombosis. J Clin Exp Hepatol (2015) 0.92
Clinical Management of Acute Portal/Mesenteric Vein Thrombosis. Viszeralmedizin (2014) 0.91
Nonsurgical Therapeutic Options in Portal Vein Thrombosis. Viszeralmedizin (2014) 0.85
Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients. HPB (Oxford) (2015) 0.84
Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran. Hepat Mon (2015) 0.79
From portal to splanchnic venous thrombosis: What surgeons should bear in mind. World J Hepatol (2014) 0.77
Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatol (2015) 0.77
Portal vein thrombosis in cirrhosis. J Clin Exp Hepatol (2013) 0.77
Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most? World J Hepatol (2015) 0.76
Systemic Venous Inflow to the Liver Allograft to Overcome Diffuse Splanchnic Venous Thrombosis. Gastroenterol Res Pract (2015) 0.75
Left branch of portal vein thrombosis in a liver transplant recipient with donation after cardiac death donor: A case report. Medicine (Baltimore) (2016) 0.75
Use of Left Gastric Vein as an Alternative for Portal Flow Reconstruction in Liver Transplantation. Case Rep Surg (2016) 0.75
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. Transplantation (2013) 0.75
Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) (2017) 0.75
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol (2006) 3.65
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology (2010) 3.53
Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc (2005) 3.28
Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg (2012) 3.28
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology (2004) 2.70
Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review. J Hepatol (2007) 2.52
The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg (2008) 2.45
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol (2008) 2.36
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl (2005) 2.35
Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl (2008) 2.30
Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review. Transpl Int (2014) 2.26
Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology (2010) 2.25
TIPS for refractory ascites: a single-centre experience. J Gastroenterol (2009) 2.19
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol (2004) 2.18
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Lancet Oncol (2011) 2.04
Hepatitis C virus infection in end-stage renal disease and kidney transplantation. Transpl Int (2014) 2.01
Shared decision making in transplantation: how patients see their role in the decision process of accepting a donor liver. Liver Transpl (2014) 2.01
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl (2007) 2.01
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88
Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int (2012) 1.87
Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl (2007) 1.87
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. J Hepatol (2007) 1.83
Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization. Ann Surg (2008) 1.79
Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75
A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl (2006) 1.73
Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg (2009) 1.70
Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl (2007) 1.68
Long-term results of urgent revascularization for hepatic artery thrombosis after pediatric liver transplantation. Liver Transpl (2010) 1.68
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66
Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol (2009) 1.65
Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission. J Gastroenterol Hepatol (2007) 1.64
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev (2006) 1.63
Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl (2009) 1.60
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Influence of steroids on HCV recurrence after liver transplantation: A prospective study. J Hepatol (2007) 1.56
Who should get a liver graft? J Hepatol (2009) 1.56
Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. J Hepatol (2012) 1.56
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54
The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis (2010) 1.53
Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation (2005) 1.52
Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation. J Gastroenterol Hepatol (2012) 1.52
Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg (2010) 1.50
Interlaboratory variability in assessment of the model of end-stage liver disease score. Liver Int (2008) 1.50
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine. Transplantation (2004) 1.49
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood (2010) 1.49
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation (2008) 1.43
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
Development and validation of a questionnaire evaluating the impact of hepatitis B immune globulin prophylaxis on the quality of life of liver transplant recipients. Liver Transpl (2012) 1.41
Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol (2012) 1.41
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver. Blood (2010) 1.40
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40
CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med (2006) 1.34
A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol (2006) 1.34
Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transpl (2006) 1.32
Biliary complications after liver transplantation: a review. Scand J Gastroenterol Suppl (2006) 1.31
Impact of blood loss on outcome after liver resection. Dig Surg (2007) 1.28
Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl (2009) 1.21
Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis. Liver Int (2012) 1.21
Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl (2009) 1.18
Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.17
beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int (2009) 1.17
Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation. Liver Int (2011) 1.15
Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression. Liver Transpl (2007) 1.12
Neurologic complications after solid organ transplantation. Transpl Int (2008) 1.12
Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol (2011) 1.11
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver Int (2011) 1.10
Immunosuppression and HCV recurrence after liver transplantation. J Hepatol (2011) 1.09
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (2011) 1.09
Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl (2010) 1.09
The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation. Liver Int (2010) 1.08
RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. J Gastroenterol Hepatol (2009) 1.08
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion (2006) 1.07
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
Bleeding in liver surgery: prevention and treatment. Clin Liver Dis (2009) 1.06
Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05
Portal vein thrombosis in cirrhosis: ignore, prevent, or treat? Gastroenterology (2012) 1.05
Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroenterol Hepatol (2009) 1.04
Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation. Liver Transpl (2007) 1.03
Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl (2011) 1.02
Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol (2011) 1.02
Towards a rational use of low-molecular-weight heparin in patients with cirrhosis. Liver Int (2011) 1.02
Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int (2011) 1.02
Optimal length of anticoagulant therapy in cirrhotic patients with portal vein thrombosis. Clin Gastroenterol Hepatol (2012) 1.02
Role of fibrin sealants in liver surgery. Dig Surg (2012) 1.01
Adrenocortical dysfunction in liver disease: a systematic review. Hepatology (2012) 0.99
Platelets in liver transplantation: friend or foe? Liver Transpl (2008) 0.99
Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl (2012) 0.99
Protection of bile ducts in liver transplantation: looking beyond ischemia. Transplantation (2011) 0.98
Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant (2005) 0.98